June, 2018 | BioBarica Profesionales

June 2018

29
Jun

Applications of Hyperbaric Oxygenation in anemias due to acute blood loss

The first time that HBOT was used as adjunctive therapy in the treatment of anemia due to acute blood loss was in 1974 by Dr. Hart. However, since the 60’s it had been used for vascular collapse with very promising results. When a patient loses a sufficient amount of blood it can compromise the adequate distribution of oxygen in the

Read more

18
Jun

Effects of physical training under hyperbaric oxygen in markers of oxidative stress and performance of Resistance in young soccer players

Hyperbaric oxygen therapy (HBOT) is the medical administration of 100% oxygen (O2) at pressures higher than 1 absolute atmosphere (ATA) and during the last decade, elite and competitive athletes have used HBOGT to accelerate the recovery after injuries or exercise-induced muscle damage. O2 plays an essential role in cell metabolism and its availability is a principal determinant of maximal O2

Read more

15
Jun

Hyperbaric oxygen therapy improves spatial learning and memory in a rat model of chronic traumatic brain injury

Traumatic brain injury  (TBI) is a disorder of major public health significance. Each year in the United States alone there are  100 new cases/100,000 population and  52,000 deaths (NIH Consensus, 1999). Most patients survive and add to an increasing prevalence of chronic TBI, estimated at 2.5 – 6.5  million individuals in 1998 (NIH Consensus, 1999). HBOT  is the use of

Read more

11
Jun

A new clinical trial for the treatment of Fibromyalgia with a hyperbaric chamber in Valencia

The study is part of the collaboration agreement recently signed by the Universitat de València, Fundación FIVAN and BioBarica. In recent years, there have been increasing scientific publications that seek to find a solution or treatment for muscle pain and fatigue suffered by people with Fibromyalgia. “This clinical trial is, for the first time, the comprehensive and comparative study of

Read more

7
Jun

BioBarica participates in the International Congress of Phlebology and Lymphology

BioBarica is present at the XVIII International Congress of Phlebology and Lymphology of the Argentine College of Venous and Lymphatic Surgery and the VII International Interuniversity Congress of Advances in Phlebology, Lymphology and Aesthetics, an event that takes place at the Intercontinental Hotel in Buenos Aires. On Friday, June 8 at 8:00 am Dr. Mariana Cannelloto, medical director of BioBarica,

Read more

7
Jun

BioBarica in the European Oncology Convention

BioBarica was present at the European Oncology Convention, the leading commercial event in Europe for professionals working to study and treat cancerous tumors. The fair was held at the ExCel exhibition center in London on June 6 and 7. It also brought together more than 100 innovative exhibitors from more than 20 countries, 85 experts who gave seminars and held

Read more

5
Jun

Why to choose BioBarica for hyperbaric oxigenation treatment?

Accessibility to medical centers Hyperbaric Medicine has evolved in the world, allowing doctors to access it as adjuvant therapy for many pathologies. The BioBarica centers use the Revitalair® 430 technology chambers, making TOHB a more accessible therapy for patients and professionals, due to the wide expansion of centers that work interconnected with each other and with standardized quality standards in

Read more

4
Jun

Hyperbaric Oxygenation Treatment in cancer patients

A tumor is an alteration of the tissues that produces an increase in volume. It is an abnormal enlargement of a part of the body that appears, therefore, swollen or distended. When cells suffer abnormal growth and have no physiological function, they tend to invade other parts of the body. There are benign tumors and malignant tumors. Benign tumors are

Read more